IP Library › Assignment 041688/0934
Patent Assignment
Reel/Frame 041688/0934

Assignment of Assignor's Interest

Recorded: 2017-03-22 Pages: 6
Assignors
KLASSEN, PRESTON
Executed: 2014-10-03
TAYLOR, KRISTIN
Executed: 2014-10-14
Assignee
OREXIGEN THERAPEUTICS, INC.
3344 NORTH TORREY PINES COURT, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Properties (2)
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent: 9,119,850 →
Application: 14/635,518 →
Publication: US 2015/0182524
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent: 9,801,875 →
Application: 14/839,792 →
Publication: US 2015/0366860
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Assignment of Assignor's Interest Sep 20, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 047115/0102 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →